Bob Kennedy’s new vaccine project is stirring up debate. With $500 million redirected from mRNA research, critics worry it might still use mRNA technology. Some argue that natural immunity is enough and that more vaccines only profit big companies. Meanwhile, Donna and Peggy encourage questioning and exploring these issues, inviting others to join their discussion. …Learn More, Click The Button Below.